Approval · Notice of Compliance 29980 · 2023
MINT-CLONIDINE: Notice of Compliance 29980
Issued January 25, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29980
- Date
- January 25, 2023
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- TEVA-CLONIDINE (Teva Canada Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-CLONIDINE | 02534738 | Marketed |
Medicinal ingredients
- CLONIDINE HYDROCHLORIDE 0.025 MG per TAB